Case Studies

  1. top
  2. Case Studies

All Case Studies

As of June, 2026

Project Modality Area Development Stage Status Result Partner
RK001 Antibody
（Nivolumab）		 Therapeutics
(Immunooncotherapy) 		Technology
development
Completed 5-Dimentional Protein Engineering
- Solubility: Enhanced
- Thermal stabilty: Preserved
- Expression level: Preserved
- Binding affinity: Secured
- Immunogenicity risk (in silico): Mitigated
RK002 Antibody
（Daratumumab）		 Therapeutics
(Oncology)		 Technology
development
Completed 3-Dimentional Protein Engineering
- Thermal stability: Enhanced
- Expression level: Elevated
- Binding affinity: Secured
RK003 Protein Therapeutics
(Rare Disease)		 Undisclosed
Completed Undisclosed
RK004 Protein Undisclosed Undisclosed
Completed Undisclosed
RK006 Protein Undisclosed Undisclosed
Completed 2-Dimentional Protein Engineering
- Bioactivity with substance A: Poteintiated
- Bioactivity with substance B: Created from ZERO		 Undisclosed
RK007 Protein Undisclosed Undisclosed
Completed 2-Dimentional Protein Engineering
- Bioactivity:Potentiated
- Expression level: Preserved
RK008 Protein Undisclosed Undisclosed
Completed 6-Dimentional Protein Engineering
- Solubility: Enhanced
- Expression level: Elevated
- Thermal stability metric 1: Enhaned
- Thermal stability metric 2: Enhanced
- Binding affinity to antigen A: Secured
- Binding affinity to antigen B:Secured		 Undisclosed
RK009 Protein Vaccines
(Infectious diseases)		 Research collaboration
Working TBD
RK010 Protein Undisclosed Undisclosed
Completed 2-Dimentional Protein Engineering
- Structurral stability at stressful physiological condition: Enhanced
- Functional stability at stressful physiological condition: Enhanced		 Undisclosed
RK011 Protein Undisclosed Undisclosed
Completed 2-Dimentional Protein Engineering
- Bioactivity: Potentiated
- Expression level: Preserved
RK012 Protein Undisclosed Undisclosed
Completed 3-Dimentional Protein Engineering
- Thermal stability: Enhanced
- Expression level: Elevated
- Binding affinity: Secured		 Undisclosed
RK013 Protein Undisclosed Undisclosed
Working TBD Undisclosed
RK014 Protein Undisclosed Undisclosed
Working TBD Undisclosed
RK015 Protein Undisclosed Undisclosed
Completed 2-Dimentional Protein Engineering
- Bioactivity: Potentiated
- Expression level: Preserved
RK016 Protein Undisclosed Undisclosed
Completed TBD
RK017 Protein Undisclosed Undisclosed
Working TBD Undisclosed
RK018 Protein Undisclosed Undisclosed
Working TBD Undisclosed
RK019 Protein Undisclosed Undisclosed
Completed 3-Dimentional Protein Engineering
- Immunogenicity risk (in silico): Mitigated
- Post-translational modification (PTM) risk: Mitigated
- Binding affinity: Tightened		 Undisclosed
RK020 Protein Undisclosed Undisclosed
Completed 3-Dimentional Protein Engineering
- Complex Formation: Enhanced
- Cell Cytotoxicity: Enhanced
- Serum Half-life: Extended		 Undisclosed
RK021 Protein Undisclosed Undisclosed
New TBD
RK022 Protein Undisclosed Undisclosed
New TBD Undisclosed

Supporting protein engineering in the pharmaceutical,
chemical, environmental,
and food industries with cutting-edge AI technology

  • High-accuracy learning from even limited experimental data
  • Applicable to proteins without established databases
  • Project-specific models with no cross-client reuse

Learn more about our technologyContact Us